vasotocin, 1-(beta-mercapto-(beta, beta-cyclopentamethylene)propionic acid)-tyr(om3)(2)-orn(8)- has been researched along with Substance Withdrawal Syndrome in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
He, C; Li, JH; Lu, CL; Song, CY; You, ZD | 1 |
1 other study(ies) available for vasotocin, 1-(beta-mercapto-(beta, beta-cyclopentamethylene)propionic acid)-tyr(om3)(2)-orn(8)- and Substance Withdrawal Syndrome
Article | Year |
---|---|
Oxytocin mediates the inhibitory action of acute lithium on the morphine dependence in rats.
Topics: Analgesics, Opioid; Animals; Antimanic Agents; Behavior, Animal; Conditioning, Psychological; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Hypothalamo-Hypophyseal System; Hypothalamus, Anterior; Lithium Chloride; Male; Morphine; Morphine Dependence; Naloxone; Narcotic Antagonists; Neurosecretion; Oxytocin; Pain Measurement; Pain Threshold; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome | 2001 |